Electrophysiology Market Expected to Reach USD 16.9 Billion by 2033, Growing at a CAGR of 8.9% from 2021

 Breaking News
  • No posts were found

Electrophysiology Market Expected to Reach USD 16.9 Billion by 2033, Growing at a CAGR of 8.9% from 2021

March 01
15:48 2024
Electrophysiology Market Expected to Reach USD 16.9 Billion by 2033, Growing at a CAGR of 8.9% from 2021
Electrophysiology Market
Electrophysiology Market Analysis and Forecast to 2033: By Product Type (Electrophysiology Ablation Catheters, Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Centers, Electrophysiology Access Devices, Others), Indication Type (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolf-Parkinson-White Syndrome, Others), End Users (Hospitals & Cardiac Centers, Ambulatory Surgery Centers), and Region.

Market Definition:

Atrial and ventricular fibrillation, tachycardia, and other diseases that have an impact on the heart are mostly diagnosed and treated with electrophysiology equipment. Healthcare professionals use a variety of tools based on the electrophysiological technique to identify and treat various disorders, including ablation and diagnostic catheters, mapping systems, etc.

To Know More: https://www.globalinsightservices.com/reports/electrophysiology-market/

Market Outlook:

The increasing incidence of target diseases and procedures is boosting the growth of the market. According to the WHO, CVD is the largest global cause of death. Age, race, and family history are significant factors influencing the increased prevalence of CVD and strokes. Other risk factors include using tobacco, having high blood pressure (hypertension), having high cholesterol, being obese, being physically inactive, having diabetes, eating unhealthily, and drinking alcohol. The prevalence of CVD is on the rise in part due to conditions like hypertension, diabetes, dyslipidemia, and obesity. By 2030, the American Heart Association projects that 41.4% of US individuals will have hypertension (an increase of 8.4 percent from 2012). Additionally, according to the organization, the cost of CVD will increase from USD 863 billion in 2010 to USD 1,044 billion by 2030. Globally, 17.9 million people passed away from CVD in 2016. According to projections, this number will reach 23.6 million by 2030.

The American Heart Association (AHA) claims that catheter-based ablation techniques have a 90% success rate, and minimal risk of complications, and allow patients to return to their regular activities in a few days. Leading businesses are investing more in the creation of novel cardiac ablation devices to increase success rates and decrease problems during procedures, including Biosense Webster, Medtronic, and Boston Scientific Corporation.

The limited effectiveness of anti-arrhythmic medications in the management of arterial filtration is another factor boosting catheter ablation demand. A study titled Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT 2) presented its findings in Massachusetts (US) in May 2012 at the Heart Rhythm Society meeting, concluding that ablation of AF, when used as a first-line method, was superior to medications that control rhythm.

Because of the intense competition among the existing competitors, the electrophysiology industry is currently quite competitive in terms of pricing. Cardiovascular 3D mapping systems and EP recording systems are two of the more expensive of these items. Cardiovascular 3D mapping systems range in price from USD 250,000 to $800,000 on average at list. A recording setup for EPs costs $160,000. EP methods are typically expensive due to the significant capital, training, and maintenance requirements. A catheter ablation procedure, for instance, typically costs between USD 4,000 and USD 6,500. Because of this and the negative reimbursement situation for these medications in many nations, a sizable portion of the intended patient group cannot afford them.

Due to factors such as healthcare provider consolidation, growing costs from the usage of complicated medical procedures, shifting governmental laws, and limited resources, the cost of developing the EP laboratory has climbed significantly over time. Even though awareness of arrhythmia and the efficacy of electrophysiological products to treat arrhythmia continues to rise in many nations, this is restricting the uptake of these devices.

Request Sample: https://www.globalinsightservices.com/request-sample/GIS10275

Research Objectives:

•            Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region

•            Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

•            Identify factors influencing market growth and challenges, opportunities, drivers and restraints

•            Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

•            Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

•            Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market

•            To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

•            Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Customization: https://www.globalinsightservices.com/request-customization/GIS10275


Global Electrophysiology Market Segmental Overview

The report analyses the global electrophysiology market based on product type, indication type, end user, and regions.

Key Players:

  • Abbott (US)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • Koninklijke Philips N.V. (Netherlands)
  • GE Healthcare (US)
  • Siemens Healthcare GmbH (Germany)
  • Stereotaxis, Inc. (US)
  • Merit Medical Systems (US)
  • Atricure Inc. (US)
  • APN Health, LLC (US)
  • Osypka Medical (Germany)
  • Japan LifeLine Co., Ltd. (Japan)
  • Johnson & Johnson (US)
  • Biotronik (Germany)
  • MicroPort Scientific Corporation (China)
  • Acutus Medical, Inc. (US)
  • Lepu Medical Technology (Beijing)
  • CathRx Ltd. (Australia)
  • Cook Medical (US)
  • CathVision ApS (Denmark)
  • TZ Medical (US)
  • Teleflex Incorporated (US)
  • Imricor (US)
  • CardioFocus (US)
  • Schwarzer Cardiotek GmbH (Germany)
  • Kardium (Canada)
  • EP Solutions SA (Switzerland)
  • BioSig Technologies Inc. (BSGM) (US)
  • Coremap (US)
  • EPMap System GmbH (Germany)

Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS10275

Research Scope:

•            Scope – Highlights, Trends, Insights. Attractiveness, Forecast

•            Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

•            Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

•            Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

•            Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

•            Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis

•            Market Size in 2021 – $7.2 bn

•            Market Size in 2031 – $16.9 bn

•            CAGR % – 8.9%

•            Historic Period – 2015-2020

•            Forecast Period – 2022-2031

•            Base Year – 2021

Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10275

About Us:

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions

• In-depth segmentation which can be customized as per your requirements

• Free consultation with lead analyst of the report

• Infographic excel data pack, easy to analyze big data

• Robust and transparent research methodology

• Unmatched data quality and after sales service


Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: [email protected]

Phone: +1-833-761-1700

Website: https://www.globalinsightservices.com/


About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Media Contact
Company Name: Global Insight Services
Contact Person: Kabita Sahu
Email: Send Email
Country: India
Website: https://www.globalinsightservices.com/

Related Articles